Pathwork Diagnostics Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$200K
Pathwork Diagnostics General Information
Description
Developer of molecular diagnostics for oncology. The company offers Pathwork tissue of origin test, a molecular diagnostics gene expression-based test that uses a tumor's genomic information to aid in the identification of tumors, including poorly differentiated, undifferentiated, and metastatic tumors. Its tissue of origin test includes lab service tests for formalin-fixed, paraffin-embedded, or frozen specimens.
Contact Information
Website
www.pathworkdx.comCorporate Office
- 595 Penobscot Drive
- Redwood City, CA 94063
- United States
Corporate Office
- 595 Penobscot Drive
- Redwood City, CA 94063
- United States
Pathwork Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 26-Aug-2013 | $200K | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series C) | 06-Oct-2010 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 04-Sep-2008 | Completed | Generating Revenue | |||
| 3. Debt - General | 11-Oct-2005 | Completed | Startup | |||
| 2. Early Stage VC (Series A1) | 24-Jun-2005 | $27.9M | $31.9M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 18-Jul-2002 | $4M | $4M | Completed | Startup |
Pathwork Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series C1 | ||||||||
| Series B | ||||||||
| Series 2 | 9,500,000 | $0.000100 | $0.09 | $1.5 | $1.5 | 1x | $1.5 | 8.3% |
| Series 1 | 2,000,000 | $0.000100 | $1.5 | $1.5 | 1x | $1.5 | 1.75% |
Pathwork Diagnostics Patents
Pathwork Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20050069863-A1 | Computer program product which use preferential transcriptional products as tool in detection and diagnosis of cell proliferative disorders; statistical modeling and disease detection | Inactive | 29-Sep-2003 | ||
| EP-1678575-A2 | Knowledge-based storage of diagnostic models | Inactive | 29-Sep-2003 | ||
| EP-1678575-A4 | Knowledge-based storage of diagnostic models | Inactive | 29-Sep-2003 | ||
| JP-2012065674-A | System and method for detecting biological feature | Inactive | 29-Sep-2003 | ||
| EP-1690086-A2 | Systems and methods for analyzing gene expression data for clinical diagnostics | Inactive | 29-Sep-2003 | G16B40/20 |
Pathwork Diagnostics Signals
Pathwork Diagnostics Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Advent Venture Partners | Venture Capital | Minority | ||
| Alta Partners | Venture Capital | Minority | ||
| Novus Ventures | Venture Capital | Minority | ||
| Prospect Venture Partners | Venture Capital | Minority |
Pathwork Diagnostics FAQs
-
When was Pathwork Diagnostics founded?
Pathwork Diagnostics was founded in 2002.
-
Where is Pathwork Diagnostics headquartered?
Pathwork Diagnostics is headquartered in Redwood City, CA.
-
What is the size of Pathwork Diagnostics?
Pathwork Diagnostics has 24 total employees.
-
What industry is Pathwork Diagnostics in?
Pathwork Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Pathwork Diagnostics a private or public company?
Pathwork Diagnostics is a Private company.
-
What is the current valuation of Pathwork Diagnostics?
The current valuation of Pathwork Diagnostics is .
-
What is Pathwork Diagnostics’s current revenue?
The current revenue for Pathwork Diagnostics is .
-
How much funding has Pathwork Diagnostics raised over time?
Pathwork Diagnostics has raised $89.4M.
-
Who are Pathwork Diagnostics’s investors?
Abingworth, Advent Venture Partners, Alta Partners, Novus Ventures, and Prospect Venture Partners are 5 of 9 investors who have invested in Pathwork Diagnostics.
-
When was Pathwork Diagnostics acquired?
Pathwork Diagnostics was acquired on 26-Aug-2013.
-
Who acquired Pathwork Diagnostics?
Pathwork Diagnostics was acquired by Response Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process